By Shimwoo Lee
Peer Reviewed
Case: A 31-year-old man with poorly controlled type 2 diabetes was hospitalized for community-acquired pneumonia. His home medications included esomeprazole. When asked why he was receiving this medication, the …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
Primecuts-This Week in the Journals
November 10, 2015
By: Loren Franco, MD
Russia has suspended all flights to Egypt amidst mounting reports and evidence that a terrorist bomb took down the Metrojet flight to St. Petersburg. Last week on October 31st, a Metrojet plane carrying 224 individuals exploded soon after …
Primecuts-This Week in the Journals
November 3, 2015
By Stephanie Wu, MD
Peer Reviewed
This past weekend, we cheered for the 50,000 people who ran the NYC marathon. Jonathan Mendes, at 94 years old, tackled this marathon for his 14th time [1]. In the midst of this momentous and triumphant occasion, we …
Supporting Evidence
October 30, 2015
By: Amy Ou
During a weekend off at my parents’ home, the subject of this chronic cough that I had developed for the entirety of the winter season came up. My mother, …
Primecuts-This Week in the Journals
October 27, 2015
By: Rory Abrams, MD
This past week the Mets became the 2015 National League Champions and are headed to the World Series. Larry David stole our hearts and minds after his impersonation of Bernie Sanders on SNL. Joe Biden …
Primecuts-This Week in the Journals
October 19, 2015
By Abinav Baweja, MD
This past week we witnessed the first democratic national debate, where Hillary Rodham Clinton quieted doubters with her strong showing and minimized talk regarding her e-mail account. Meanwhile, ex-NBA …
Beta-blockers in Uncomplicated Hypertension: Is it Time for Retirement?
October 7, 2015
By Robin Guo, MD
Peer Reviewed
Beta-blockers were one of the first modern medications used for the treatment of blood pressure. Before 1950, treatment options for hypertension were limited. The alphabet soup of …
Primecuts – This Week In The Journals
October 5, 2015
Olivia Begasse de Dhaem, MD
Peer Reviewed
Last month, Turing Pharmaceutical bought the rights to pyrimethamine, also known as Daraprim, and subsequently raised its price significantly (from $13.5 to $750 per tablet). Unlike Rodelis Therapeutics …